BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

被引:19
|
作者
Erturk, Elif [1 ]
Cecener, Gulsah [2 ]
Tezcan, Gulcin [2 ,3 ]
Egeli, Unal [2 ]
Tunca, Berrin [2 ]
Gokgoz, Sehsuvar [4 ]
Tolunay, Sahsine [5 ]
Tasdelen, Ismet [4 ]
机构
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Dept Med Biol, Fac Med, Bursa, Turkey
[3] Uludag Univ, Inst Hlth Sci, Dept Med Biol, Bursa, Turkey
[4] Uludag Univ, Dept Gen Surg, Fac Med, Bursa, Turkey
[5] Uludag Univ, Dept Pathol, Fac Med, Bursa, Turkey
关键词
Triple negative breast cancer; MicroRNA; BRCA1/2 gene mutations; miR-200c; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; OVARIAN-CANCER; FEEDBACK LOOP; FAMILY; ZEB1; MICRORNA-200C; PROGRESSION; METASTASIS; RESISTANCE;
D O I
10.1016/j.gene.2014.11.047
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [21] Regulation of AdipoR2 expression by MiR-200c and MiR-200b in colorectal cancer
    Cai, C. X.
    Liu, Y. L.
    Gu, X. B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 225 - 226
  • [22] MIR-200C EXPRESSION IN THAI PATIENTS WITH CHOLANGIOCARCINOMA
    Loywirat, W.
    Sriuranpong, V.
    Tanasanvimon, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E61 - E62
  • [23] Expression and functional role of miR-200c in rhabdomyosarcoma
    Herrmann, D.
    Seitz, G.
    Warmann, S.
    Bonin, M.
    Leuschner, I
    Fuchs, J.
    Armeanu-Ebinger, S.
    KLINISCHE PADIATRIE, 2010, 222 (03): : 219 - 220
  • [24] Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
    Evans, D. G.
    Howell, A.
    Ward, D.
    Lalloo, F.
    Jones, J. L.
    Eccles, D. M.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (08) : 520 - 522
  • [25] Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer
    Roh, Mee Sook
    Lee, Hyoun Wook
    Jung, Sang Bong
    Kim, Kyungeun
    Lee, Eun Hee
    Park, Moon-il
    Lee, Jae Seok
    Kim, Mee-Seon
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (03) : 350 - 355
  • [26] Serum miR-200c expression level as a prognostic biomarker for gastric cancer
    Zhang, H. -P.
    Sun, F. -B.
    Li, S. -J.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 15913 - 15920
  • [27] Evaluation of BRCA1 mutations in patients with triple negative breast cancer
    Ellsworth, Rachel E.
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    CANCER RESEARCH, 2012, 72
  • [28] Prevalence of BRCA1 mutations in triple negative breast cancer (BC).
    Kandel, M. J.
    Stadler, Z.
    Masciari, S.
    Collins, L.
    Schnitt, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 5S - 5S
  • [29] Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
    Pogoda, Katarzyna
    Niwinska, Anna
    Sarnowska, Elzbieta
    Nowakowska, Dorota
    Jagiello-Gruszfeld, Agnieszka
    Siedlecki, Janusz
    Nowecki, Zbigniew
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [30] BRCA mutations in triple negative breast cancer patients in Guatemala: A descriptive study
    Kihn-Alarcon, Alba
    Marroquin Flores, Diana Beatriz
    de Falla, Vicky
    Siliezar, Mauricio
    Silva, Carlos
    Velarde, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)